- Home
- MLCO vs LMAT Comparison
MLCO vs LMAT Comparison
Compare MLCO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCO
- LMAT
- Stock Information
- Founded
- MLCO 2004
- LMAT 1983
- Country
- MLCO Hong Kong
- LMAT United States
- Employees
- MLCO N/A
- LMAT N/A
- Industry
- MLCO Hotels/Resorts
- LMAT Medical/Dental Instruments
- Sector
- MLCO Consumer Discretionary
- LMAT Health Care
- Exchange
- MLCO Nasdaq
- LMAT Nasdaq
- Market Cap
- MLCO N/A
- LMAT 1.9B
- IPO Year
- MLCO 2006
- LMAT 2006
- Fundamental
- Price
- MLCO $5.99
- LMAT $80.26
- Analyst Decision
- MLCO Buy
- LMAT Buy
- Analyst Count
- MLCO 5
- LMAT 7
- Target Price
- MLCO $7.24
- LMAT $100.67
- AVG Volume (30 Days)
- MLCO 5.3M
- LMAT 187.8K
- Earning Date
- MLCO 05-08-2025
- LMAT 05-01-2025
- Dividend Yield
- MLCO N/A
- LMAT 0.99%
- EPS Growth
- MLCO N/A
- LMAT 30.45
- EPS
- MLCO 0.14
- LMAT 1.97
- Revenue
- MLCO $4,758,114,000.00
- LMAT $226,256,000.00
- Revenue This Year
- MLCO $8.32
- LMAT $11.00
- Revenue Next Year
- MLCO $4.04
- LMAT $8.48
- P/E Ratio
- MLCO $41.06
- LMAT $40.86
- Revenue Growth
- MLCO 14.07
- LMAT 13.19
- 52 Week Low
- MLCO $4.55
- LMAT $71.42
- 52 Week High
- MLCO $8.90
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- MLCO 71.35
- LMAT 39.99
- Support Level
- MLCO $4.95
- LMAT $78.01
- Resistance Level
- MLCO $6.09
- LMAT $83.51
- Average True Range (ATR)
- MLCO 0.24
- LMAT 3.21
- MACD
- MLCO 0.12
- LMAT -0.88
- Stochastic Oscillator
- MLCO 92.31
- LMAT 14.87
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.